SEBORRHEIC DERMATITIS

Clinical trials for SEBORRHEIC DERMATITIS explained in plain language.

Never miss a new study

Get alerted when new SEBORRHEIC DERMATITIS trials appear

Sign up with your email to follow new studies for SEBORRHEIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2 Completed 2

New skin lotion enters first human safety tests for common rash

Disease control Not yet recruiting

This study is testing a new topical lotion called ZYG24002 for adults with mild to moderate seborrheic dermatitis, a common skin condition causing redness, scaling, and itch. The main goal is to check the safety and side effects of three different strengths of the lotion when app…

Matched conditions: SEBORRHEIC DERMATITIS

Phase: PHASE1 • Sponsor: Sinomune Pharmaceutical Co., Ltd • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

SEBORRHEIC DERMATITIS

Get alerted when new SEBORRHEIC DERMATITIS trials appear

New skin lotion enters first human safety tests for common rash